Company / Revenue
AIM ImmunoTech Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$88.0K
FY2025
5-year range
$88.0K / $202.0K
FY2021-FY2025
Trend
-56.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $88,000 in FY2025 to $367,000 in FY2018.
Based on SEC 10-K filings.
$88,000 in FY2025 with a 5-year CAGR of -11.6%.
Declined from $141,000 to $88,000 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -13.3%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -11.6%, indicating a declining trend.
- In FY2025, revenue decreased 56.4% year-over-year.
- Peak revenue was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $88.0K | -56.4% |
| FY2024 | $202.0K | +43.3% |
| FY2023 | $141.0K | +4.4% |
| FY2022 | $135.0K | -17.2% |
| FY2021 | $163.0K | +0.0% |
| FY2020 | $163.0K | +16.4% |
| FY2019 | $140.0K | -61.9% |
| FY2018 | $367.0K | +175.9% |
| FY2017 | $133.0K | +44.6% |
| FY2016 | $92.0K | -30.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026